cYY | CAS#1361200-34-1 | metabolite

MedKoo Cat#: 565791 | Name: cYY

Description:

WARNING: This product is for research use only, not for human or veterinary use.

cYY is a metabolite, naturally generated through mycobacterium tuberculosis cyp121a1

Chemical Structure

cYY

CAS#1361200-34-1

Theoretical Analysis

MedKoo Cat#: 565791

Name: cYY

CAS#: 1361200-34-1

Chemical Formula: C18H18N2O4

Exact Mass: 326.1267

Molecular Weight: 326.35

Elemental Analysis: C, 66.25; H, 5.56; N, 8.58; O, 19.61

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

cYY; cyclo-L-Tyr-L-Tyr; Cyclo-di-L-tyrosine

IUPAC/Chemical Name

(3S,6S)-3,6-Bis(4-hydroxybenzyl)piperazine-2,5-dione

InChi Key

NGPCLOGFGKJCBP-HOTGVXAUSA-N

InChi Code

InChI=1S/C18H18N2O4/c21-13-5-1-11(2-6-13)9-15-17(23)20-16(18(24)19-15)10-12-3-7-14(22)8-4-12/h1-8,15-16,21-22H,9-10H2,(H,19,24)(H,20,23)/t15-,16-/m0/s1

SMILES Code

O=C([C@H](CC1=CC=C(O)C=C1)N2)N[C@@H](CC3=CC=C(O)C=C3)C2=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 326.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: El-Wahab HAAA, Accietto M, Marino LB, McLean KJ, Levy CW, Abdel-Rahman HM, El-Gendy MA, Munro AW, Aboraia AS, Simons C. Design, synthesis and evaluation against Mycobacterium tuberculosis of azole piperazine derivatives as dicyclotyrosine (cYY) mimics. Bioorg Med Chem. 2018 Jan 1;26(1):161-176. doi: 10.1016/j.bmc.2017.11.030. Epub 2017 Nov 21. PubMed PMID: 29183661. 2: Fielding AJ, Dornevil K, Ma L, Davis I, Liu A. Probing Ligand Exchange in the P450 Enzyme CYP121 from Mycobacterium tuberculosis: Dynamic Equilibrium of the Distal Heme Ligand as a Function of pH and Temperature. J Am Chem Soc. 2017 Dec 6;139(48):17484-17499. doi: 10.1021/jacs.7b08911. Epub 2017 Nov 20. PubMed PMID: 29090577; PubMed Central PMCID: PMC5765751. 3: Park M, Watanabe S, Poon VY, Ou CY, Jorgensen EM, Shen K. CYY-1/cyclin Y and CDK-5 differentially regulate synapse elimination and formation for rewiring neural circuits. Neuron. 2011 May 26;70(4):742-57. doi: 10.1016/j.neuron.2011.04.002. PubMed PMID: 21609829; PubMed Central PMCID: PMC3168547. 4: Kishk SM, McLean KJ, Sood S, Helal MA, Gomaa MS, Salama I, Mostafa SM, de Carvalho LPS, Munro AW, Simons C. Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1. Bioorg Med Chem. 2019 Apr 15;27(8):1546-1561. doi: 10.1016/j.bmc.2019.02.051. Epub 2019 Feb 27. PubMed PMID: 30837169. 5: Fonvielle M, Le Du MH, Lequin O, Lecoq A, Jacquet M, Thai R, Dubois S, Grach G, Gondry M, Belin P. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures. J Biol Chem. 2013 Jun 14;288(24):17347-59. doi: 10.1074/jbc.M112.443853. Epub 2013 Apr 25. PubMed PMID: 23620594; PubMed Central PMCID: PMC3682536. 6: Zhu X, McAtee CC, Schindler CS. Scalable Synthesis of Mycocyclosin. Org Lett. 2018 May 18;20(10):2862-2866. doi: 10.1021/acs.orglett.8b00894. Epub 2018 Apr 27. PubMed PMID: 29701978. 7: Dornevil K, Davis I, Fielding AJ, Terrell JR, Ma L, Liu A. Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from Mycobacterium tuberculosis proceeds through a catalytic shunt pathway. J Biol Chem. 2017 Aug 18;292(33):13645-13657. doi: 10.1074/jbc.M117.794099. Epub 2017 Jun 30. PubMed PMID: 28667013; PubMed Central PMCID: PMC5569305. 8: Belin P, Le Du MH, Fielding A, Lequin O, Jacquet M, Charbonnier JB, Lecoq A, Thai R, Courçon M, Masson C, Dugave C, Genet R, Pernodet JL, Gondry M. Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2009 May 5;106(18):7426-31. doi: 10.1073/pnas.0812191106. Epub 2009 Apr 22. PubMed PMID: 19416919; PubMed Central PMCID: PMC2678619. 9: Ou CY, Poon VY, Maeder CI, Watanabe S, Lehrman EK, Fu AK, Park M, Fu WY, Jorgensen EM, Ip NY, Shen K. Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components. Cell. 2010 May 28;141(5):846-58. doi: 10.1016/j.cell.2010.04.011. PubMed PMID: 20510931; PubMed Central PMCID: PMC3168554. 10: Duffell KM, Hudson SA, McLean KJ, Munro AW, Abell C, Matak-Vinković D. Nanoelectrospray ionization mass spectrometric study of Mycobacterium tuberculosis CYP121-ligand interactions. Anal Chem. 2013 Jun 18;85(12):5707-14. doi: 10.1021/ac400236z. Epub 2013 May 29. PubMed PMID: 23675886. 11: Li Z, Li WX. [Acupoint catgut-embedding for 78 cases of allergic rhinitis]. Zhongguo Zhen Jiu. 2013 Mar;33(3):211-2. Chinese. PubMed PMID: 23713300. 12: Migliavacca R, Migliavacca A, Nucleo E, Ciaponi A, Spalla M, De Luca C, Pagani L. Molecular epidemiology of ESbetaL producing P. mirabilis strains from a long-term care and rehabilitation facility in Italy. New Microbiol. 2007 Jul;30(3):362-6. PubMed PMID: 17802927. 13: Mishima M, Matsuoka M, Lei YX, Rappoport Z. Gas-phase acidities of disubstituted methanes and of enols of carboxamides substituted by electron-withdrawing groups. J Org Chem. 2004 Sep 3;69(18):5947-65. PubMed PMID: 15373479. 14: Zhang P, Liu Y, Fu C, Wang C, Duan X, Zou W, Zhao T. Knockdown of long non-coding RNA PCAT1 in glioma stem cells promotes radiation sensitivity. Med Mol Morphol. 2019 Jun;52(2):114-122. doi: 10.1007/s00795-018-0209-8. Epub 2018 Dec 18. PubMed PMID: 30564876. 15: Jeon SY, Lee NR, Yim CY. Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report. BMC Nephrol. 2019 Jan 3;20(1):1. doi: 10.1186/s12882-018-1181-1. PubMed PMID: 30606155; PubMed Central PMCID: PMC6318841.